By Michael Dabaie Biogen Inc. and Eisai Co. said the First Committee on New Drugs of Japan s Pharmaceutical Affairs and Food Sanitation Council decided to continue deliberations on the. | December 22, 2021
In the zuranolone 50 mg cohort, the majority of patients who responded to an initial 14-day course received only one two-week course of treatment during the study and nearly 80% received only one or. | December 1, 2021
Eli Lilly on Tuesday raised its
2021 profit forecast, citing the strength in its core business
and higher sales of its COVID-19 antibody therapies, and said it
started the application process for the. | October 26, 2021
A U.S. House panel said on Friday it
would examine the approval and pricing of Biogen Inc s
Alzheimer s drug, Aduhelm. Biogen had announced a list price of $56,000 per year for
the. | June 26, 2021